EBIT at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's EBIT?
- Beam Therapeutics (BEAM) reported EBIT of -$107.22M in Q1 2026.
- How has Beam Therapeutics's EBIT changed year-over-year?
- Beam Therapeutics's EBIT increased by 10.1% year-over-year, from -$119.29M to -$107.22M.
- What is the long-term trend for Beam Therapeutics's EBIT?
- Over 3 years (2021 to 2025), Beam Therapeutics's EBIT has grown at a -0.8% compound annual growth rate (CAGR), from -$392.47M to -$383.69M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.